India Cord Blood Banking Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

India Cord Blood Banking Market was valued at USD 35.38 Million in 2024 and is expected to reach USD 46.37 Million by 2030 with a CAGR of 4.81% during the forecast period. The cord blood banking market in India is undergoing rapid evolution, reflecting a growing awareness of its potential benefits and expanding opportunities within the healthcare sector. Cord blood, which is the blood left in the umbilical cord and placenta after childbirth, is rich in hematopoietic stem cells that can be used for treating a range of medical conditions, including certain cancers, genetic disorders, and blood diseases.

Private cord blood banks have been at the forefront of this growth, offering services to store a family’s own cord blood for personal use. These banks have seen an uptick in demand due to the perceived value of having a readily available stem cell source for the child or family members in case of medical emergencies. The marketing efforts of private cord blood banks, coupled with advances in technology, have contributed to increasing consumer confidence and interest in these services.

Public cord blood banks, on the other hand, focus on collecting and storing cord blood donations for use by patients in need, irrespective of familial relations. This model is gaining momentum due to its potential to provide life-saving treatments to a broader patient base. Public banks are supported by government initiatives and collaborations with healthcare institutions, further driving their growth.

Several factors are driving the expansion of the cord blood banking market in India. First and foremost is the increasing awareness and education regarding the benefits of stem cell therapy. Healthcare professionals and media campaigns have played a crucial role in informing the public about the potential life-saving applications of cord blood stem cells, leading to a growing number of parents considering cord blood banking.

Despite the positive trends, the cord blood banking market in India faces several challenges. One of the primary issues is the high cost associated with private cord blood banking services. The financial burden of storing cord blood can be a deterrent for many families, particularly in a price-sensitive market like India.

Key Market Drivers

Growing Prevalence of Autoimmune Diseases

The increasing prevalence of autoimmune diseases in India is emerging as a significant driver for the country's cord blood banking market. Autoimmune diseases, wherein the immune system mistakenly attacks the body's own tissues, are on the rise, reflecting a broader trend observed globally. This growing health challenge is catalyzing interest in cord blood banking due to the potential of stem cells derived from umbilical cord blood in treating various autoimmune conditions.

Autoimmune diseases encompass a range of conditions where the immune system's malfunction results in chronic inflammation and damage to healthy tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. These conditions can be debilitating, requiring long-term management and, in some cases, innovative treatments. The increasing incidence of autoimmune diseases in India, driven by genetic, environmental, and lifestyle factors, is creating a heightened demand for effective treatment options.

A report published in 2023 indicates that women in India are more susceptible to autoimmune diseases compared to men. Autoimmune diseases occur when the immune system mistakenly targets and attacks the body's own healthy cells and tissues, unable to distinguish between the body's own cells and foreign entities. Experts estimate that approximately 80% of individuals diagnosed with autoimmune diseases are women.

Cord blood banking, which involves collecting and storing the blood from a newborn's umbilical cord for potential future medical use, is gaining prominence due to its potential therapeutic benefits. Cord blood is rich in hematopoietic stem cells, which have the ability to differentiate into various types of cells and have shown promise in treating a range of conditions, including autoimmune diseases. The growing recognition of the potential benefits of cord blood stem cells is driving interest in cord blood banking as a preventive measure.

One of the key factors influencing this trend is the increasing awareness among expectant parents about the role of stem cells in treating autoimmune diseases. As knowledge about the potential applications of cord blood stem cells spreads, more families are considering cord blood banking as a safeguard against future health issues. The ability to access a valuable source of stem cells for potential use in treating autoimmune diseases is a compelling incentive for many parents.

The expanding prevalence of autoimmune diseases is prompting both private and public cord blood banks to increase their outreach and services. Private cord blood banks are focusing on educating potential clients about the benefits of cord blood stem cells in treating autoimmune conditions, while public banks are emphasizing the importance of cord blood donation for broader therapeutic use.

The future of the cord blood banking market in India appears promising, driven by the growing prevalence of autoimmune diseases. As the incidence of these conditions continues to rise, the demand for stem cell therapies is expected to increase, bolstering the cord blood banking sector. Continued advancements in research, coupled with supportive policies and increased public awareness, will likely drive further growth and innovation in the market.

Increased Number of Hospitals and Clinics Offering Cord Blood Banking

One of the most notable trends in the Indian healthcare sector is the integration of cord blood banking into routine childbirth services. Hospitals and clinics across the country are increasingly incorporating cord blood banking as part of their standard delivery packages. This integration ensures that expectant parents are presented with the option of cord blood banking at a crucial decision-making point, thereby increasing the likelihood of its adoption. The convenience of having cord blood banking services available at the point of delivery removes barriers related to awareness and accessibility, making it easier for families to choose this service.

The expansion of healthcare facilities in India has played a crucial role in the proliferation of cord blood banking services. As the healthcare infrastructure improves and more hospitals and clinics are established, there is a corresponding increase in the availability of specialized services such as cord blood banking. This expansion is particularly evident in tier-2 and tier-3 cities, where previously such services were limited. By extending cord blood banking services beyond major metropolitan areas, healthcare providers are catering to a larger and more diverse population, thus driving market growth.

Currently, India's healthcare infrastructure is extensive, spanning from primary healthcare centers to advanced tertiary care hospitals. As one of the largest healthcare systems globally, it is projected to expand to USD 50 billion by 2033, fueled by rising investments from both public and private sectors. Presently, developers are partnering with healthcare providers to establish state-of-the-art facilities in metropolitan areas as well as tier 2 and tier 3 cities, thereby broadening access to high-quality healthcare for a greater segment of the population.

The growing number of hospitals and clinics offering cord blood banking has led to the development of comprehensive service packages that include not only the collection and storage of cord blood but also detailed consultation services for expectant parents. These packages often include educational resources, risk assessments, and customized plans based on individual family needs. By providing a more holistic service experience, healthcare providers are increasing the appeal of cord blood banking and encouraging more families to opt for it.

According to a report published by the Ministry of Health and Family Welfare in 2022, India has 3,840 licensed blood banks across the country. The Government of India, through the National Health Mission, aids States and Union Territories in enhancing their healthcare systems, which includes strengthening existing blood banks and establishing new ones. Additionally, the Blood Transfusion Services support 1,131 public and charitable sector blood banks by providing resources such as manpower, blood bags, testing kits, and organizing voluntary blood donation (VBD) camps and information, education, and communication (IEC) activities. The government also supplies mobile vans for blood collection and transportation to various States and Union Territories.

The availability of cord blood banking services in a wider range of healthcare facilities has a direct impact on patient decision-making. When expectant parents have easy access to information and services related to cord blood banking during their prenatal visits or hospital stays, they are more likely to make informed decisions about banking their child’s cord blood. The presence of these services in trusted healthcare settings reassures parents and underscores the importance of cord blood as a valuable resource for potential future medical treatments.

Key Market Challenges

High Cost Associated with Cord Blood Banking

Cord blood banking represents a significant advancement in medical science, offering the potential for life-saving treatments through stem cell therapies. However, one of the most formidable challenges facing the cord blood banking industry in India is the high cost associated with this service. This financial barrier impacts both market growth and accessibility, posing a challenge to broader adoption of cord blood banking in the country.

The process of cord blood banking involves several stages, including collection, processing, and storage, each of which incurs substantial costs. Initially, the collection of cord blood requires specialized medical personnel and equipment. This step involves extracting blood from the umbilical cord immediately after birth, a procedure that must be conducted under sterile conditions to ensure the viability of the stem cells. The need for trained professionals and sterile equipment contributes to the high costs of the initial collection.

Following collection, the cord blood undergoes a complex processing procedure designed to isolate and preserve the stem cells. This step involves sophisticated laboratory techniques and state-of-the-art technology to ensure the cells remain viable for future use. The processing stage is both labor-intensive and technically demanding, requiring significant investment in advanced technology and skilled personnel.

Once processed, the cord blood must be stored in cryogenic conditions to maintain its integrity over time. This long-term storage involves maintaining extremely low temperatures in specialized cryogenic tanks, which requires continuous monitoring and maintenance. The infrastructure necessary for this storage, such as temperature-controlled environments and backup power systems adds further to the overall cost.

For many families, these costs translate into a significant financial burden. According to a report published by Kauvery Hospital, many parents are interested in banking their babies' cord blood to protect their families' health. As a result, most cord blood banks charge an upfront fee covering collection, processing, and cryopreservation. For example, some banks may charge around USD 1,191.09, which includes the cost of the collection kit and transportation of the cord blood. Additionally, there is an annual storage fee of approximately USD 714.65. For a substantial portion of the population, these expenses are prohibitive, especially when viewed in the context of India’s diverse economic landscape. High costs create a barrier for many potential clients, limiting access to this potentially life-saving service and hindering widespread adoption.

Key Market Trends

Growth of Stem Cell Research

The Indian cord blood banking market is undergoing a significant transformation, largely driven by the rapid advancement of stem cell research. This burgeoning field is reshaping the landscape of cord blood banking in India, creating new opportunities and driving market growth. As scientific understanding and technological capabilities in stem cell research expand, they are bringing renewed attention and investment to cord blood banking, highlighting its crucial role in the future of medical treatment and healthcare.

Stem cell research has made remarkable strides in recent years, showcasing the vast potential of stem cells in regenerative medicine and the treatment of a variety of diseases. Stem cells, particularly those derived from umbilical cord blood, have shown promise in treating conditions such as leukemia, lymphoma, and certain genetic disorders. This potential has generated increased interest among researchers, healthcare providers, and prospective parents in the importance of cord blood banking.

In February 2022, the Government of India advanced stem cell research by leveraging various departments and institutions. This effort included support for both fundamental and clinical research through national funding agencies such as the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT), and the Department of Science and Technology (DST). These initiatives have led to the development of cutting-edge infrastructure at more than 40 leading health research and educational institutions, as well as bolstering industry efforts within India.

In India, the growth of stem cell research is directly influencing the cord blood banking market. The country’s investment in cutting-edge research and development is leading to the discovery of new therapeutic applications for stem cells. As clinical trials advance and demonstrate the efficacy of stem cell treatments, the demand for stored cord blood is anticipated to rise. This growing demand is prompting more parents to consider cord blood banking as a proactive measure for their children’s future health.

Several factors are contributing to the increased emphasis on stem cell research in India. Firstly, the Indian government and private sector are investing heavily in biotechnology and healthcare infrastructure. Research institutions and biotech firms are focusing on the development of advanced stem cell therapies, supported by both public funding and private investment. This investment is crucial in fostering innovation and translating research findings into viable treatments.

Moreover, partnerships between Indian cord blood banks and research institutions are strengthening the sector. These collaborations facilitate access to state-of-the-art research and technologies, ensuring that cord blood banks are equipped to handle and preserve stem cells at the highest standards. Such partnerships also enhance the credibility and appeal of cord blood banking services, as they align with the latest advancements in stem cell research.

Segmental Insights

Service Insights

Based on Service, Sample Preservation & Storage have emerged as the fastest growing segment in the India Cord Blood Banking Market in 2024. Effective preservation and storage of cord blood samples are crucial due to the unique nature of stem cells and their use in future medical treatments. Once collected, cord blood must be processed and stored under highly controlled conditions to ensure the viability of stem cells for potential therapeutic use. The process involves several critical steps: collection, processing, cryopreservation, and long-term storage. Each step must be meticulously managed to maintain the quality and potency of the stem cells, which can significantly impact their effectiveness in future treatments.

The growth of the cord blood banking market in India reflects an increasing understanding of the long-term benefits of preserving high-quality stem cell samples. Advances in cryopreservation technology have improved the ability to maintain stem cells in a viable state over extended periods, enhancing the market's attractiveness. As a result, parents are increasingly recognizing the value of investing in cord blood banking for potential future medical needs, driving demand for reliable preservation and storage solutions.

Technological advancements in cryopreservation and storage techniques are a key driver behind the growing emphasis on sample preservation in the Indian cord blood banking market. Innovations in freezing methods, such as controlled-rate freezing and vitrification, have significantly improved the efficiency and effectiveness of stem cell preservation. These technologies ensure that stem cells remain viable and functional, even after years of storage.

The development of sophisticated storage systems that maintain optimal temperatures and conditions for cord blood samples is also contributing to market growth. Advanced storage facilities equipped with state-of-the-art freezers and monitoring systems provide an added layer of assurance for parents investing in cord blood banking. The ability to offer long-term storage with high levels of reliability and security is becoming a competitive advantage for cord blood banks in India.

Component Insights

Based on Component, Cord Blood have emerged as the dominating segment in the India Cord Blood Banking Market during the forecast period. One of the primary drivers behind the dominance of cord blood banking in India is the increasing awareness and education surrounding its benefits. Over recent years, public awareness campaigns and educational initiatives have played a crucial role in informing expectant parents about the value of cord blood. This increased knowledge has highlighted the potential of stem cells for treating a range of medical conditions, including certain cancers, genetic disorders, and autoimmune diseases. As parents become more informed about the long-term health benefits and the potential to use cord blood for future medical treatments, they are more likely to invest in cord blood banking services.

The advancement of medical research and technology has significantly contributed to the prominence of cord blood banking. Research has continually expanded the range of diseases and conditions that can be treated using stem cells derived from cord blood. Breakthroughs in stem cell therapies and clinical trials have demonstrated the potential of cord blood in regenerative medicine, leading to increased demand for these services. As medical science progresses, the range of applications for cord blood stem cells continues to grow, reinforcing its importance and appeal to prospective parents.

Supportive regulatory frameworks and government policies have also played a pivotal role in the growth of the cord blood banking market. The Indian government has introduced regulations and guidelines to ensure the quality and safety of cord blood banking services. These regulatory measures help build consumer confidence and ensure that cord blood banks adhere to high standards of practice. Additionally, government-backed health programs and incentives that promote stem cell research and cord blood banking contribute to the expansion of the market.

The increased availability and accessibility of cord blood banking services across India have been instrumental in driving market dominance. The rise in the number of hospitals and clinics offering cord blood banking as part of their childbirth packages has made these services more accessible to a broader segment of the population. By integrating cord blood banking into routine healthcare services, healthcare providers facilitate easier decision-making for expectant parents, thereby boosting adoption rates.

Regional Insights

Based on Region, West India have emerged as the dominating region in the India Cord Blood Banking Market in 2024. One of the primary drivers of West India's prominence in the cord blood banking sector is its well-developed healthcare infrastructure. The region, particularly Maharashtra and Gujarat, is home to a significant number of advanced medical facilities and institutions. Cities such as Mumbai and Pune in Maharashtra, and Ahmedabad and Surat in Gujarat, boast state-of-the-art hospitals and specialized healthcare centers that are equipped with the necessary technology and expertise for cord blood collection and processing. The presence of these high-quality medical facilities provides a strong foundation for the growth and development of cord blood banking services.

Furthermore, West India benefits from a high concentration of affluent and educated families who are more likely to invest in advanced medical services, including cord blood banking. The region's economic prosperity has led to an increased focus on healthcare and preventive measures, with many families seeking to safeguard their health through the use of innovative technologies. This economic advantage translates into higher demand for cord blood banking services, driving the growth of the market in West India.

The region has also seen a significant rise in public awareness and education regarding the benefits of cord blood banking. Healthcare providers and cord blood banks in West India have undertaken extensive educational campaigns to inform expectant parents about the potential life-saving advantages of storing cord blood stem cells. Increased awareness and understanding of the value of cord blood for treating various diseases have led to higher adoption rates among families in West India.

Additionally, West India’s strategic geographic location enhances its position in the cord blood banking market. The region’s well-connected transport and logistics networks facilitate the efficient collection, processing, and storage of cord blood. Major cities in West India have access to advanced transportation infrastructure, including airports and ports, which ensures that cord blood can be quickly and safely transported to processing facilities. This logistical efficiency is crucial for maintaining the viability of the cord blood stem cells and ensuring timely delivery.

Key Market Players

• Cryoviva Biotech Pvt. Ltd.
• LifeCell International Pvt Ltd.
• Cordlife Sciences India Pvt Ltd.
• Regrow Biosciences Pvt. Ltd.
• ReeLabs Pvt. Ltd.
• StemCyte India Therapeutics Pvt. Ltd.
• Reliance Life Sciences Pvt. Ltd./India.

Report Scope

In this report, the India Cord Blood Banking Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

India Cord Blood Banking Market, By Service:

• Sample Preservation & Storage
• Sample Analysis
• Sample Processing
• Sample Collection & Transportation

India Cord Blood Banking Market, By Component:

• Cord Blood
• Cord Tissue

India Cord Blood Banking Market, By Application:

• Cancer Disease
• Diabetes
• Blood Disease
• Immune Disorders
• Metabolic Disorders
• Others

India Cord Blood Banking Market, By Sector:

• Public Cord Blood Banks
• Private cord Blood Banks

India Cord Blood Banking Market, By Region:

• North India
• East India
• West India
• South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Cord Blood Banking Market.

Available Customizations:

India Cord Blood Banking Market report with the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.